Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 162
Infectious Diseases Drugs 123
Genomics 101
Liver and Kidney Disorders Drugs 68
Immune Disorders Drugs 61
Pharmaceuticals 51
Drug Discovery 48
Cardiovascular Drugs 44
Biopharmaceuticals 42
Biotechnology 41
Leukemia Drugs 36
HIV/AIDS Drugs 36
Lymphoma Drugs 29
Allergy and Immunology 28
Clinical Trials 28
Musculoskeletal Disorders Drugs 27
Enzymes 26
Respiratory Drugs 26
Oncology 22
Pulmonary Medicine 21
Central Nervous System Drugs 20
Infusions and Injectables 19
Drug Delivery 19
Pharmaceutical Manufacturing 17
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 11
Healthcare Services 10
Diagnostics 10
Hematology 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Drugs by Therapeutic Area 6
Women's Health 6
Lung Cancer Drugs 6
Company Reports 5
Hepatology 5
Colon Cancer Drugs 5
Analgesics 5
Needles and Syringes 5
Nanomedicine 5
Cervical Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Liver Cancer Drugs 3
Generic Drugs 3
Bladder Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
E-Healthcare 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



282 reviews

1,019 Results (Page 33 of 51)
- Relevance
  Sort by

Small Molecules Drugs for Inflammatory Bowel Diseases Market - Global Forecast 2026-2032

 Report
January 2026
189 Pages
Global

From

€3173EUR$3,545USD£2,772GBP

€3526EUR$3,939USD£3,080GBP

Gastrointestinal Diseases Therapeutics Market - Global Forecast 2026-2032

 Report
January 2026
183 Pages
Global

From

€3173EUR$3,545USD£2,772GBP

€3526EUR$3,939USD£3,080GBP

Small Molecule Drug Discovery - Global Strategic Business Report

 Report
April 2026
376 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Sickle Cell Treatment Market - Global Forecast to 2030

 Report
August 2025
185 Pages
Global

From

€3173EUR$3,545USD£2,772GBP

€3526EUR$3,939USD£3,080GBP

DNA Repair Drugs - Global Strategic Business Report

 Report
April 2026
217 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Leukocyte Adhesion Deficiency Management Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

Anemia and Other Blood Disorder Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

Cancer Antibody Drug Conjugates Market - Global Strategic Business Report

 Report
April 2026
482 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Personalized Cancer Medicines Market - Global Strategic Business Report

 Report
April 2026
267 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Blood Cancer Therapeutics - Global Strategic Business Report

 Report
April 2026
291 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Chemotherapy Treatment - Global Strategic Business Report

 Report
April 2026
188 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Blastic Plasmacytoid Dendritic Cell Neoplasm - Global Strategic Business Report

 Report
April 2026
285 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Cancer Biological Therapy - Global Strategic Business Report

 Report
April 2026
211 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Tendonitis Treatment Drug Market - Global Forecast to 2030

 Report
August 2025
186 Pages
Global

From

€3173EUR$3,545USD£2,772GBP

€3526EUR$3,939USD£3,080GBP

Africa Anti - Rheumatic Drugs Market - Forecasts from 2025 to 2030

 Report
August 2025
148 Pages
Africa

From

€2909EUR$3,250USD£2,541GBP

Antibody Drug Conjugates (ADC) - Global Strategic Business Report

 Report
April 2026
193 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Sickle Cell Disease Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

Sickle Cell Disease- Pipeline Insight, 2025

 Clinical Trials
April 2025
180 Pages
Global

From

€2238EUR$2,500USD£1,955GBP

Company Snapshots: US Biotechnology

 Newsletter
April 2026
35 Pages
United States

From

€269EUR$300USD£235GBP

Hypophosphatasia Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

1,019 Results (Page 33 of 51)
- 1
- 31
- 32
- 33
- 34
- 35

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.